Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Other financing activities: 2022-2023

Historic Other financing activities for Lexeo Therapeutics (LXEO) over the last 1 years, with Dec 2023 value amounting to $3.0 million.

  • Lexeo Therapeutics' Other financing activities rose 70.53% to $3.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $5.3 million, marking a year-over-year change of. This contributed to the annual value of $12.5 million for FY2024, which is 309.92% up from last year.
  • Per Lexeo Therapeutics' latest filing, its Other financing activities stood at $3.0 million for Q4 2023, which was up 247.31% from $873,000 recorded in Q3 2023.
  • Lexeo Therapeutics' 5-year Other financing activities high stood at $3.0 million for Q4 2023, and its period low was $397,000 during Q1 2023.
  • Its 2-year average for Other financing activities is $1.2 million, with a median of $921,000 in 2023.
  • Data for Lexeo Therapeutics' Other financing activities shows a peak YoY skyrocketed of 102.55% (in 2023) over the last 5 years.
  • Lexeo Therapeutics' Other financing activities (Quarterly) stood at $1.8 million in 2022, then spiked by 70.53% to $3.0 million in 2023.
  • Its Other financing activities was $3.0 million in Q4 2023, compared to $873,000 in Q3 2023 and $969,000 in Q2 2023.